Close Menu

What's Hot

This week, Genetic Engineering & Biotechnology News' Harry Glorikian and Brian Clancy round up what they call "sequencing trends worth watching." The first, they say, is the polarization of sequencing activity — "an increasing share of total high-throughput sequencing activity being conducted by the largest and smallest sequencing labs … driven by a series of centralization and decentralization forces that are acting on the space simultaneously." Glorikian and Clancy sug

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Nature News reports the US National Institutes of Health is investing in studies of the long-term effects of COVID-19.

The National Health Service is to offer Novartis's Zolgensma for spinal muscular atrophy later this year, according to the Guardian.

Taiwan is to launch a pilot program offering genetic testing to cancer patients, the Taipei Times reports.

In PLOS this week: loci linked to protection against tuberculosis, identification of loci associated with increased risk of squamous cell carcinoma of the aerodigestive tract, and more.